Blood Pressure Effects of Sodium Reduction
Background:
The relationship between dietary sodium intake and blood pressure (BP) has been tested in clinical trials and nonexperimental human studies, indicating a direct association. The exact shape of the dose–response relationship has been difficult to assess in clinical trials because of the lack of random-effects dose–response statistical models that can include 2-arm comparisons.
Methods:
After performing a comprehensive literature search for experimental studies that investigated the BP effects of changes in dietary sodium intake, we conducted a dose–response meta-analysis using the new 1-stage cubic spline mixed-effects model. We included trials with at least 4 weeks of follow-up; 24-hour urinary sodium excretion measurements; sodium manipulation through dietary change or supplementation, or both; and measurements of systolic and diastolic BP at the beginning and end of treatment.
Results:
We identified 85 eligible trials with sodium intake ranging from 0.4 to 7.6 g/d and follow-up from 4 weeks to 36 months. The trials were conducted in participants with hypertension (n=65), without hypertension (n=11), or a combination (n=9). Overall, the pooled data were compatible with an approximately linear relationship between achieved sodium intake and mean systolic as well as diastolic BP, with no indication of a flattening of the curve at either the lowest or highest levels of sodium exposure. Results were similar for participants with or without hypertension, but the former group showed a steeper decrease in BP after sodium reduction. Intervention duration (≥12 weeks versus 4 to 11 weeks), type of study design (parallel or crossover), use of antihypertensive medication, and participants’ sex had little influence on the BP effects of sodium reduction. Additional analyses based on the BP effect of difference in sodium exposure between study arms at the end of the trial confirmed the results on the basis of achieved sodium intake.
Conclusions:
In this dose–response analysis of sodium reduction in clinical trials, we identified an approximately linear relationship between sodium intake and reduction in both systolic and diastolic BP across the entire range of dietary sodium exposure. Although this occurred independently of baseline BP, the effect of sodium reduction on level of BP was more pronounced in participants with a higher BP level.
Top-30
Journals
|
2
4
6
8
10
12
14
16
|
|
|
Hypertension
16 publications, 7.08%
|
|
|
Nutrients
13 publications, 5.75%
|
|
|
Journal of Hypertension
10 publications, 4.42%
|
|
|
Circulation
7 publications, 3.1%
|
|
|
Frontiers in Nutrition
4 publications, 1.77%
|
|
|
Hypertension Research
4 publications, 1.77%
|
|
|
Nutrition, Metabolism and Cardiovascular Diseases
4 publications, 1.77%
|
|
|
Blood Pressure
3 publications, 1.33%
|
|
|
Journal of the American Heart Association
3 publications, 1.33%
|
|
|
Journal of Human Hypertension
3 publications, 1.33%
|
|
|
High Blood Pressure and Cardiovascular Prevention
3 publications, 1.33%
|
|
|
Current Hypertension Reports
3 publications, 1.33%
|
|
|
Environmental Research
3 publications, 1.33%
|
|
|
Journal of Clinical Hypertension
3 publications, 1.33%
|
|
|
Current Opinion in Cardiology
2 publications, 0.88%
|
|
|
Journal of Clinical Medicine
2 publications, 0.88%
|
|
|
Current Nutrition Reports
2 publications, 0.88%
|
|
|
Current environmental health reports
2 publications, 0.88%
|
|
|
Cancer Epidemiology Biomarkers and Prevention
2 publications, 0.88%
|
|
|
JAMA - Journal of the American Medical Association
2 publications, 0.88%
|
|
|
Current Atherosclerosis Reports
2 publications, 0.88%
|
|
|
JAMA network open
2 publications, 0.88%
|
|
|
Food and Function
2 publications, 0.88%
|
|
|
BMC Public Health
2 publications, 0.88%
|
|
|
Current Developments in Nutrition
2 publications, 0.88%
|
|
|
Scientific Reports
2 publications, 0.88%
|
|
|
The Lancet Public Health
2 publications, 0.88%
|
|
|
JAMA Cardiology
2 publications, 0.88%
|
|
|
Journal of the American College of Cardiology
2 publications, 0.88%
|
|
|
2
4
6
8
10
12
14
16
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
42 publications, 18.58%
|
|
|
Springer Nature
41 publications, 18.14%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
38 publications, 16.81%
|
|
|
MDPI
21 publications, 9.29%
|
|
|
Wiley
12 publications, 5.31%
|
|
|
Taylor & Francis
7 publications, 3.1%
|
|
|
Oxford University Press
7 publications, 3.1%
|
|
|
Frontiers Media S.A.
6 publications, 2.65%
|
|
|
American Medical Association (AMA)
6 publications, 2.65%
|
|
|
BMJ
4 publications, 1.77%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 1.77%
|
|
|
American Physiological Society
3 publications, 1.33%
|
|
|
SAGE
3 publications, 1.33%
|
|
|
Public Library of Science (PLoS)
2 publications, 0.88%
|
|
|
Georg Thieme Verlag KG
2 publications, 0.88%
|
|
|
American Association for Cancer Research (AACR)
2 publications, 0.88%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 0.88%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 0.88%
|
|
|
IMR Press
2 publications, 0.88%
|
|
|
The Endocrine Society
1 publication, 0.44%
|
|
|
Hellenic Cardiological Society
1 publication, 0.44%
|
|
|
American Society for Nutrition
1 publication, 0.44%
|
|
|
Cambridge University Press
1 publication, 0.44%
|
|
|
Mary Ann Liebert
1 publication, 0.44%
|
|
|
Silicea - Poligraf, LLC
1 publication, 0.44%
|
|
|
IOP Publishing
1 publication, 0.44%
|
|
|
Hans Publishers
1 publication, 0.44%
|
|
|
Centre for Evaluation in Education and Science (CEON/CEES)
1 publication, 0.44%
|
|
|
Hindawi Limited
1 publication, 0.44%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.